TARA Mind Announces $8 Million in Seed Funding to Expand Affordable Access to Life-Changing Mental Health Therapeutics

TARA Mind, a public benefit corporation focused on creating access to safe and effective ketamine-assisted therapy (KAT) as a covered benefit for employees, announced today that the Company has raised $8 million, led by Satori Neuro. Additional investors participating in the oversubscribed round were Echo Investment Capital, Crumpton Ventures, Empath Ventures, and Blake Mykoskie: Founder of TOMS.

Founded in 2022 by Marcus Capone, a Veteran Navy SEAL turned Entrepreneur after experiencing the life-changing benefits of psychedelic-assisted therapy, TARA Mind is advancing its mission to provide safe, effective, and affordable access to life-changing mental health therapies through its collaborative care platform and structured real world evidence dataset. The Company has developed a first of its kind mental health collaborative care platform, recognized for being clinician-guided, data-driven and evidence-based, to help the millions of individuals struggling with mental health disorders that have not been clinically responsive to traditional mental health therapies. Many of these individuals represent the highest risk/highest cost segment of the workforce.

Read more at Business Wire

Share

Related Posts